Neprilysin Inhibits Coagulation through Proteolytic Inactivation of Fibrinogen

Neprilysin (NEP) is an endogenous protease that degrades a wide range of peptides including amyloid beta (Aβ), the main pathological component of Alzheimer’s disease (AD). We have engineered NEP as a potential therapeutic for AD but found in pre-clinical safety testing that this variant increased pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Burrell, Matthew, Henderson, Simon J., Ravnefjord, Anna, Schweikart, Fritz, Fowler, Susan B., Witt, Susanne, Hansson, Kenny M., Webster, Carl I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954676/
https://www.ncbi.nlm.nih.gov/pubmed/27437944
http://dx.doi.org/10.1371/journal.pone.0158114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954676/
https://www.ncbi.nlm.nih.gov/pubmed/27437944
http://dx.doi.org/10.1371/journal.pone.0158114

Ejemplares similares